Titre:
  • Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer.
Auteur:Burstein, Harold J; Sun, Yan; Dirix, Luc Y; Jiang, Zefei; Paridaens, R.; Tan, Antoinette R; Awada, Ahmad; Ranade, Anantbhushan; Jiao, Shunchang; Schwartz, Gary; Abbas, Richat; Powell, Christine; Turnbull, Kathleen; Vermette, Jennifer; Zacharchuk, Charles; Badwe, Rajendra
Informations sur la publication:Journal of clinical oncology, 28, 8, page (1301-1307)
Statut de publication:Publié, 2010-03
Sujet CREF:Sciences bio-médicales et agricoles
Note générale:Journal Article
Langue:Anglais
Identificateurs:urn:issn:0732-183X
info:doi/10.1200/JCO.2009.25.8707
info:pii/JCO.2009.25.8707
info:pmid/20142587